retatrutide peptide therapy 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Why Retatrutide Is Gaining Attention

Beyond weight loss, studies show the drugs can lower the risk of heart attack, stroke and even reduce sleep apnea

Adverse reactions: mild transient diarrhea, polycythemia vera, peripheral vascular thrombosis, transient rash itching, bloating sensation

The American Telemedicine Association notes that as of 2024, 43 states require a valid prescriber-patient relationship before any prescription, including a GLP-1, can be issued via telehealth 10

Their findings suggest that future trials conducted on chromiums effect on body composition should last for a longer time at least about 16 weeks for better assessment

View in: Pubmed Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFN

doi: 10.1016/j.biopha.2024.117177 120 BohnTde LeraARLandrierJFRuhlR